IONS logo

Ionis Pharmaceuticals, Inc. (IONS) Return On Equity

Annual ROE:

-93.10%-16.76%(-21.95%)
December 31, 2024

Summary

  • As of today, IONS annual return on equity is -93.10%, with the most recent change of -16.76% (-21.95%) on December 31, 2024.
  • During the last 3 years, IONS annual ROE has fallen by -89.32% (-2362.96%).
  • IONS annual ROE is now -147.12% below its all-time high of 197.56%, reached on December 31, 2004.

Performance

IONS ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONSprofitability metrics

Quarterly ROE:

-43.01%+8.07%(+15.80%)
September 1, 2025

Summary

  • As of today, IONS quarterly return on equity is -43.01%, with the most recent change of +8.07% (+15.80%) on September 1, 2025.
  • Over the past year, IONS quarterly ROE has increased by +50.13% (+53.82%).
  • IONS quarterly ROE is now -103.05% below its all-time high of 1410.79%, reached on June 30, 1999.

Performance

IONS Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONSprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

IONS ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-21.9%+53.8%
3Y3 Years-2363.0%-3840.0%
5Y5 Years-537.3%-963.6%

IONS ROE Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-2363.0%at low-3840.0%+60.2%
5Y5-Year-537.3%at low-963.6%+60.2%
All-TimeAll-Time-147.1%+98.6%-103.0%+99.0%

IONS ROE History

DateAnnualQuarterly
Sep 2025
-
-43.01%(+15.8%)
Jun 2025
-
-51.08%(+49.0%)
Mar 2025
-
-100.07%(+3.0%)
Dec 2024
-93.10%(-22.0%)
-103.19%(-10.8%)
Sep 2024
-
-93.14%(+13.8%)
Jun 2024
-
-108.09%(-7.6%)
Mar 2024
-
-100.47%(-20.2%)
Dec 2023
-76.34%(-90.3%)
-83.57%(+2.0%)
Sep 2023
-
-85.30%(-49.6%)
Jun 2023
-
-57.00%(-3.7%)
Mar 2023
-
-54.96%(-33.6%)
Dec 2022
-40.12%(-961.4%)
-41.13%(-3676.5%)
Sep 2022
-
1.15%(+126.4%)
Jun 2022
-
-4.36%(-651.7%)
Mar 2022
-
-0.58%(+86.5%)
Dec 2021
-3.78%(+90.4%)
-4.31%(+94.1%)
Sep 2021
-
-73.52%(-35.9%)
Jun 2021
-
-54.09%(-28.9%)
Mar 2021
-
-41.97%(-25.9%)
Dec 2020
-39.52%(-285.6%)
-33.34%(-769.5%)
Sep 2020
-
4.98%(-42.2%)
Jun 2020
-
8.61%(-19.2%)
Mar 2020
-
10.65%(-49.7%)
Dec 2019
21.29%(-24.2%)
21.19%(-33.3%)
Sep 2019
-
31.79%(-1.2%)
Jun 2019
-
32.19%(-7.0%)
Mar 2019
-
34.61%(+15.8%)
Dec 2018
28.10%(+751.5%)
29.88%(+283.3%)
Sep 2018
-
-16.30%(+9.5%)
Jun 2018
-
-18.01%(-124.3%)
Mar 2018
-
-8.03%(-280.6%)
Dec 2017
3.30%(+105.7%)
-2.11%(-118.3%)
Sep 2017
-
11.50%(-54.8%)
Jun 2017
-
25.46%(+346.5%)
Mar 2017
-
-10.33%(+83.1%)
Dec 2016
-57.64%(-49.7%)
-61.01%(+43.2%)
Sep 2016
-
-107.49%(+3.8%)
Jun 2016
-
-111.71%(-96.1%)
Mar 2016
-
-56.96%(-65.2%)
Dec 2015
-38.50%(-214.0%)
-34.48%(-791.0%)
Sep 2015
-
4.99%(-33.8%)
Jun 2015
-
7.54%(+200.0%)
Mar 2015
-
-7.54%(+33.4%)
Dec 2014
-12.26%(+43.3%)
-11.32%(+55.2%)
Sep 2014
-
-25.28%(-5.4%)
Jun 2014
-
-23.99%(+6.7%)
Mar 2014
-
-25.70%(-32.6%)
Dec 2013
-21.61%(+41.5%)
-19.38%(-34.8%)
Sep 2013
-
-14.38%(+38.7%)
Jun 2013
-
-23.47%(+6.5%)
Mar 2013
-
-25.11%(+36.4%)
Dec 2012
-36.97%(+9.3%)
-39.46%(+20.6%)
Sep 2012
-
-49.70%(-20.7%)
Jun 2012
-
-41.18%(+12.0%)
Mar 2012
-
-46.78%(-15.1%)
Dec 2011
-40.77%(-81.9%)
-40.66%(-16.2%)
Sep 2011
-
-35.00%(-30.6%)
Jun 2011
-
-26.79%(+4.8%)
Mar 2011
-
-28.13%(-23.7%)
Dec 2010
-22.41%(-30.2%)
-22.74%(+0.1%)
Sep 2010
-
-22.77%(-15.7%)
Jun 2010
-
-19.68%(-72.0%)
Mar 2010
-
-11.44%(-120.4%)
Dec 2009
-17.21%(-18.5%)
56.12%(-27.3%)
Sep 2009
-
77.15%(-21.6%)
Jun 2009
-
98.38%(-24.0%)
Mar 2009
-
129.43%(+8826.2%)
Dec 2008
-14.52%
1.45%(+100.6%)
Sep 2008
-
-229.44%(+8.7%)
Jun 2008
-
-251.41%(+17.2%)
DateAnnualQuarterly
Mar 2008
-
-303.78%(+1.3%)
Dec 2007
-64.32%(+53.1%)
-307.90%(-350.3%)
Sep 2007
-
-68.38%(+21.2%)
Jun 2007
-
-86.77%(+17.9%)
Mar 2007
-
-105.63%(+27.7%)
Dec 2006
-137.07%(+95.0%)
-146.08%(+51.3%)
Sep 2006
-
-299.84%(+93.0%)
Jun 2006
-
-4278.21%(-2331.3%)
Mar 2006
-
191.74%(+46.7%)
Dec 2005
-2716.74%(-1475.1%)
130.67%(-20.6%)
Sep 2005
-
164.66%(-6.2%)
Jun 2005
-
175.49%(-45.2%)
Mar 2005
-
320.01%(+116.4%)
Dec 2004
197.56%(+331.5%)
-1948.31%(-614.1%)
Sep 2004
-
-272.82%(-81.8%)
Jun 2004
-
-150.04%(-40.9%)
Mar 2004
-
-106.49%(-26.3%)
Dec 2003
-85.33%(-123.6%)
-84.33%(-31.6%)
Sep 2003
-
-64.09%(-20.4%)
Jun 2003
-
-53.21%(-15.0%)
Mar 2003
-
-46.25%(-20.2%)
Dec 2002
-38.17%(+25.2%)
-38.49%(+3.7%)
Sep 2002
-
-39.98%(+7.0%)
Jun 2002
-
-43.01%(+20.9%)
Mar 2002
-
-54.35%(+26.7%)
Dec 2001
-51.01%(+67.9%)
-74.14%(+31.4%)
Sep 2001
-
-108.07%(+5.3%)
Jun 2001
-
-114.10%(-15.8%)
Mar 2001
-
-98.50%(+7.6%)
Dec 2000
-159.10%(+97.7%)
-106.61%(+32.9%)
Sep 2000
-
-159.00%(+47.3%)
Jun 2000
-
-301.59%(+82.8%)
Mar 2000
-
-1752.32%(-317.1%)
Dec 1999
-6815.30%(-2331.2%)
807.02%(+19.3%)
Sep 1999
-
676.66%(-52.0%)
Jun 1999
-
1410.79%(+287.6%)
Mar 1999
-
-751.93%(-96.8%)
Dec 1998
-280.33%(-320.7%)
-382.04%(-157.8%)
Sep 1998
-
-148.21%(-20.1%)
Jun 1998
-
-123.39%(-40.7%)
Mar 1998
-
-87.67%(-28.4%)
Dec 1997
-66.64%(-68.7%)
-68.29%(-22.0%)
Sep 1997
-
-55.97%(+3.3%)
Jun 1997
-
-57.90%(-18.4%)
Mar 1997
-
-48.91%(-22.4%)
Dec 1996
-39.51%(-1.5%)
-39.96%(-11.2%)
Sep 1996
-
-35.95%(+10.2%)
Jun 1996
-
-40.03%(+2.7%)
Mar 1996
-
-41.14%(+12.2%)
Dec 1995
-38.91%(-11.8%)
-46.85%(+12.8%)
Sep 1995
-
-53.70%(-8.2%)
Jun 1995
-
-49.64%(-14.7%)
Mar 1995
-
-43.28%(-31.6%)
Dec 1994
-34.80%(+10.3%)
-32.88%(-7.5%)
Sep 1994
-
-30.60%(-3.6%)
Jun 1994
-
-29.54%(-0.2%)
Mar 1994
-
-29.47%(+25.0%)
Dec 1993
-38.78%(+1.6%)
-39.28%(+8.9%)
Sep 1993
-
-43.10%(-1.2%)
Jun 1993
-
-42.60%(-5.1%)
Mar 1993
-
-40.53%(-3.1%)
Dec 1992
-39.42%(-37.7%)
-39.31%(-8.1%)
Sep 1992
-
-36.36%(-11.1%)
Jun 1992
-
-32.72%(+1.0%)
Mar 1992
-
-33.05%(-5.0%)
Dec 1991
-28.62%(+89.2%)
-31.48%(+5.7%)
Sep 1991
-
-33.38%(-0.8%)
Jun 1991
-
-33.13%(+45.4%)
Mar 1991
-
-60.69%(+76.6%)
Dec 1990
-264.71%
-258.82%

FAQ

  • What is Ionis Pharmaceuticals, Inc. annual return on equity?
  • What is the all-time high annual ROE for Ionis Pharmaceuticals, Inc.?
  • What is Ionis Pharmaceuticals, Inc. annual ROE year-on-year change?
  • What is Ionis Pharmaceuticals, Inc. quarterly return on equity?
  • What is the all-time high quarterly ROE for Ionis Pharmaceuticals, Inc.?
  • What is Ionis Pharmaceuticals, Inc. quarterly ROE year-on-year change?

What is Ionis Pharmaceuticals, Inc. annual return on equity?

The current annual ROE of IONS is -93.10%

What is the all-time high annual ROE for Ionis Pharmaceuticals, Inc.?

Ionis Pharmaceuticals, Inc. all-time high annual return on equity is 197.56%

What is Ionis Pharmaceuticals, Inc. annual ROE year-on-year change?

Over the past year, IONS annual return on equity has changed by -16.76% (-21.95%)

What is Ionis Pharmaceuticals, Inc. quarterly return on equity?

The current quarterly ROE of IONS is -43.01%

What is the all-time high quarterly ROE for Ionis Pharmaceuticals, Inc.?

Ionis Pharmaceuticals, Inc. all-time high quarterly return on equity is 1410.79%

What is Ionis Pharmaceuticals, Inc. quarterly ROE year-on-year change?

Over the past year, IONS quarterly return on equity has changed by +50.13% (+53.82%)
On this page